2026 Oncology Drug Development Planning Realities

Read article

Case Study: Rapid Phase I Study Start-Up and Conduct

A European client contracted with Medelis to conduct…
Read Article

Therapies That Might Affect the Cancer-Immunity Cycle

In the last five years we’ve seen a…
Read Article

Monitoring irAEs and SAEs in Oncology Immunotherapy Studies

In a previous post, we discussed site selection…
Read Article

Site Selection for Cancer Immunotherapy Studies

Rapid advances in cancer immunotherapy treatments have fueled…
Read Article

ASCO 2017

The ASCO 2017 Annual Meeting in Chicago from…
Read Article

ASH 2016 Annual Meeting – Say Hello

It’s almost December, and that means it’s time…
Read Article

Dr. Ron van Eijsden Joins Medelis, a Specialty Oncology CRO, as Managing Director, Medelis Europe

Nashville, TN – November 1, 2016 – Medelis,…
Read Article

Specialty CROs, WCCT Global and Medelis, Announce Merger to Deliver Expanded Oncology and Clinical Research Services

CYPRESS, Calif., June 1, 2016 /PRNewswire/ -- WCCT Global,…
Read Article

Medelis Partners with The McGuire Institute to Continue Raising the Standards of Clinical Dentistry Research

Today, Medelis is proud to announce our partnership…
Read Article